NO20010049L - Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn - Google Patents

Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn

Info

Publication number
NO20010049L
NO20010049L NO20010049A NO20010049A NO20010049L NO 20010049 L NO20010049 L NO 20010049L NO 20010049 A NO20010049 A NO 20010049A NO 20010049 A NO20010049 A NO 20010049A NO 20010049 L NO20010049 L NO 20010049L
Authority
NO
Norway
Prior art keywords
amygdalin
substance
treatment
amplification procedure
assessing
Prior art date
Application number
NO20010049A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010049D0 (no
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of NO20010049D0 publication Critical patent/NO20010049D0/no
Publication of NO20010049L publication Critical patent/NO20010049L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010049A 2000-01-17 2001-01-04 Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn NO20010049L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000008337A JP2001199892A (ja) 2000-01-17 2000-01-17 アミグダリン含有物の抗腫瘍活性強化方法、抗腫瘍活性強化アミグダリン含有物を含む組成物、アミグダリン含有物処理の抗腫瘍有効性評価方法、およびアミグダリン含有物の抗腫瘍有効性評価方法

Publications (2)

Publication Number Publication Date
NO20010049D0 NO20010049D0 (no) 2001-01-04
NO20010049L true NO20010049L (no) 2001-07-18

Family

ID=18536624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010049A NO20010049L (no) 2000-01-17 2001-01-04 Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn

Country Status (19)

Country Link
US (2) US20010009903A1 (it)
JP (1) JP2001199892A (it)
KR (1) KR20010076279A (it)
CN (1) CN1319431A (it)
AU (1) AU1502101A (it)
CA (1) CA2331167A1 (it)
DE (1) DE10101543A1 (it)
DK (1) DK200100086A (it)
ES (1) ES2166741B1 (it)
FR (1) FR2805746A1 (it)
GB (1) GB2360211A (it)
ID (1) ID29765A (it)
IL (1) IL140900A0 (it)
IS (1) IS5804A (it)
IT (1) ITTO20010028A1 (it)
NL (1) NL1017117C2 (it)
NO (1) NO20010049L (it)
SE (1) SE0100083L (it)
ZA (1) ZA200100377B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3256746B2 (ja) * 2000-03-02 2002-02-12 高知医科大学長 細胞線維化を抑制する組成物及び枇杷核エキスの調製方法
KR100470294B1 (ko) * 2002-08-20 2005-02-05 (주) 한약마을 도인 또는 행인으로부터 아미그달린을 효과적으로 얻는추출방법
GB0402728D0 (en) * 2004-02-07 2004-03-10 Pharming Ltd Pesticides
JP2006197928A (ja) * 2004-12-22 2006-08-03 Yamaguchi Prefecture タケノコ麹及びその製造方法並びにタケノコ醗酵食品及びその製造方法
JP4974116B2 (ja) * 2005-06-27 2012-07-11 国立大学法人 鹿児島大学 ビワ葉抽出物を含有する飲食品及び医薬品
CN101190019B (zh) * 2006-11-21 2011-03-09 马玉林 杏仁酱及其制备方法
CN107400150A (zh) * 2017-08-16 2017-11-28 黄山市歙县绿色三潭枇杷生物科技有限公司 一种从枇杷核中提取苦杏仁苷的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6379834A (ja) * 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
JPH06227998A (ja) * 1993-01-28 1994-08-16 Sanji Kumai ニトリル配糖体を含有する生薬エキスの制癌活性
GB2314800A (en) * 1996-12-05 1998-01-14 Henry Berry & Co Ltd Component assembly machine

Also Published As

Publication number Publication date
ITTO20010028A0 (it) 2001-01-16
ES2166741A1 (es) 2002-04-16
AU1502101A (en) 2001-07-19
SE0100083D0 (sv) 2001-01-12
ZA200100377B (en) 2001-07-18
CN1319431A (zh) 2001-10-31
SE0100083L (sv) 2001-07-18
NO20010049D0 (no) 2001-01-04
GB0101181D0 (en) 2001-02-28
GB2360211A (en) 2001-09-19
IS5804A (is) 2001-07-17
US20010009903A1 (en) 2001-07-26
US20020098252A1 (en) 2002-07-25
ES2166741B1 (es) 2003-11-16
NL1017117C2 (nl) 2003-09-30
JP2001199892A (ja) 2001-07-24
FR2805746A1 (fr) 2001-09-07
ID29765A (id) 2001-10-11
DE10101543A1 (de) 2001-07-19
KR20010076279A (ko) 2001-08-11
NL1017117A1 (nl) 2001-07-19
CA2331167A1 (en) 2001-07-17
DK200100086A (da) 2001-07-18
IL140900A0 (en) 2002-02-10
ITTO20010028A1 (it) 2002-07-16

Similar Documents

Publication Publication Date Title
Sabino et al. Light-based technologies for management of COVID-19 pandemic crisis
Shen et al. Detoxification of aflatoxins in foods by ultraviolet irradiation, hydrogen peroxide, and their combination-a review
Komine et al. A small amount of singlet oxygen generated via excited methylene blue by photodynamic therapy induces the sterilization of Enterococcus faecalis
Duckhouse et al. The effect of sonication on microbial disinfection using hypochlorite
da Silva et al. Fast elimination of onychomycosis by hematoporphyrin derivative-photodynamic therapy
Oruba et al. Antimicrobial photodynamic therapy—A discovery originating from the pre-antibiotic era in a novel periodontal therapy
WO2002038447A3 (en) Disinfection through packaging
Tavares et al. The impact of antimicrobial photodynamic therapy on peri-implant disease: What mechanisms are involved in this novel treatment?
JP2009013162A (ja) 光感作型ざ瘡治療剤、光感作型ざ瘡治療剤の組成物、光力学的ざ瘡治療用キット、光感作型皮脂分泌抑制剤、光感作型皮脂分泌抑制剤の組成物および光力学的皮脂分泌抑制剤キット
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
NO20010049L (no) Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn
SG169224A1 (en) Method for treatment of tumors using nordihydrogualaretic acid derivatives
Riley et al. An in-vitro study of the sterilization of titanium dental implants using low intensity UV-radiation
Choi et al. Plasma bioscience for medicine, agriculture and hygiene applications
Shivasaraun et al. Flavonoids as adjuvant in psoralen based photochemotherapy in the management of vitiligo/leucoderma
Papastamou et al. Photoinactivation of F. nucleatum and P. gingivalis using the ruthenium-based RD3 sensitizer and a conventional halogen lamp
Kreitner et al. Haematoporphyrin-and sodium chlorophyllin-induced phototoxicity towards bacteria and yeasts–a new approach for safe foods
Moideen et al. Photoeradication of aquatic pathogens by curcumin for clean and safe drinking water
Hirakawa et al. Guanine-specific DNA damage photosensitized by the dihydroxo (tetraphenylporphyrinato) antimony (V) complex
AU2003283227A8 (en) Method and means for the treatment of vascular and cardiac diseases
Xu et al. Photochemical properties of gemifloxacin: A laser flash photolysis study
Babando Ozone therapy in dentistry: clinical experiences
de Araújo et al. Treatment of recurrent herpes of the lower lip skin region with photodynamic therapy and photobiomodulation: case report
RU2002118587A (ru) Способ снижения микробиологической обсемененности поверхности хлеба
Ramu et al. The enhancement of riboflavin-mediated photo-oxidation of doxorubicin by histidine and urocanic acid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application